AZ, Sanofi target Aust for RSV

By Megan Brodie 1 year ago | In Companies, Regulatory, Vaccines
  • 1 year ago

26 September 2022 AstraZeneca and Sanofi are negotiating to file their single-dose, passive immunisation antibody…

This is subscriber-only content. Please login to continue reading.